ArticlePDF Available

A double-blind, randomized controlled trial on the use of malunggay (Moringa oleifera) for augmentation of the volume of breastmilk among non-nursing mothers of preterm infants

Authors:

Abstract

OBJECTIVES: To determine if there is a significant difference in the volume of breastmilk on postpartum days 3 to 5 among mothers with preterm infants who were randomized to take malunggay (Moringa oleifera) leaves compared to those who were given placebo. SETTING: Tertiary government hospital STUDY DESIGN: Double-blind, randomized controlled trial PATIENTS AND METHODS: A total of 68 postpartum mothers admitted in a tertiary government hospital and whose infants had pediatric ages of less than 37 weeks and admitted to the NICU for tube feedings were included in the study. The mothers were randomized to receive Moringa oleifera(encapsulated in a commercial preparation containing 250 mg of leaves) or an identical capsule containing flour as placebo. Participants were asked to express milk using a standardized breastpump from day 1 to day 5 postpartum. The mothers were given capsules on postpartum days 3 to 5 . The contents of the capsules were unknown to both Investigator and subjects. T-test was used to determine differences in quantitative baseline variables. Chi-square was used to determine difference in baseline proportions. One- way ANOVA was used to determine if there were significant differences in the volume of breastmilk between treatment and control groups. A p-value of <0.05 was considered significant. RESULTS: There was a trend towards increased milk production among those on Moringa oleifera leaves (Day 3: 114.1 ml ± 62.9 vs. 87.2 ± 49.1; Day 4: 190 ml ± 103.5 vs. 128.8 ± 84.9; Day 5: 319.7 ml ± 154.10 vs. 120.2 ±54.7). This was statistically significant on Day 4 (p =0.007) and on Day 5 (p = 0.000). CONCLUSION: Moringa oleifera leaves increase milk production on postpartum days 4 to 5 among mothers who delivered preterm infants. KEYWORDS: breastmilk, malunggay
ORIGINAL ARTICLES
A double-blind, randomized controlled
trial
on
the
use
of
malunggay
(Moringa
oleifera)
for augmentation of the volume ofbreastmilk among
non-nursing mothers
of
preterm
infants
Ma. Corazon
P.
Estrella, M.D.,
Jacinto
Bias
V.
Man
taring
III,
M.D.,
Grace
Z. David, M.D.,
Michelle
A.
Taup, M.D.*
ABSTRACT
OBJECTIVES:
To
determine
if
there is a significant difference in the
volume
of
breastmilk on postpartum days 3
to
5 among mothers with
,preterm infants
who
take
malunggay
(Moringa oleifera) leaves com-
pared to those
who
were given placebo.
SETTING: Tertiary government hospital
STUDY DESIGN: Double-blind, randomized controlled trial
PATIENTS
AND
METHODS: A total
of
68
postpartum mothers admit-
ted at a tertiary government hospital and whose infants had pediatric
ages
of
less than
37
weeks and admitted
to
the NICU
for
tube feedings
were included in the study. The mothers were randomized to receive
Moringa oleifera(encapsulated in a commercial preparation contain-
ing 250 mg
of
leaves)
or
an identical capsule containing
flour
as pla-
cebo. They were asked
to
pump their breasts using a standardized
breastpump
from
day 1
to
day 5 postpartum. The mothers were given
capsules on postpartum days 3
to
5 . The contents
Of
the capsules
were unknown
to
both Investigator and subjects. T-test was used
to
determine differences in baseline variables. Chi-square was used to
determine difference in baseline
proportions
between groups. One-
way ANOVA was used
to
determine
if
there were significant differences
in the volume
of
breastmilk between treatment and control groups. A
p-value
of
<0.05 was considered significant.
RESULTS:
There was a trend towards increased milk production among
those on Moringa oleifera leaves (Day 3:
114.1
ml ± 62.9 vs. 87.2 ±
49.1;
Day
4:
190 ml ± 103.5 vs. 128.8 ± 84.9; Day 5: 319.7 ml ± 154.10
vs. 120.2 ± 54.7). This was statistically significant on Day 4 (p = 0.007)
and on Day 5 (p = 0.000).
CONCLUSION: Moringa oleifera leaves increase
milk
production on
postpartum days 4
to
5 among mothers
who
delivered preterm in-
fants.
KEYWORDS: breastmilk,
malunggay
Feeding breastmilk to premature in-
fants
is
of
interest because
of
its potential
nutritional and immunologic benefits. The
prevailing consensus is that early milk pro-
* From the Department
of
Pediatrics,
UP-
PGH Medical Center
Vol.
49
No.
1 January-March 2000
duced by women who deliver prematurely
is
more appropriate for VLBW infants than
is donor milk from later stages
of
lactation,
and that is to feed each infant milk pro-
duced by his/her mother minimizes poten-
tial risks from contaminants. To implement
this consensus, mothers
ofVLBW
infants
must produce sufficient milk to meet the
nutritional needs imposed by the acceler-
ated growth rates
of
their infants. More
often than not, however, the biggest ob-
stacle to the initiation
of
feeding breast
milk is collection. Most mothers after initi-
ating expression
of
breastmilk on the first
few days after birth complain
of
insuffi-
cient volume ofbreastmilk. This complaint
has prompted most mothers
to
use milk
formula, shift to bottle feeding, and dis-
continue breastfecding.
Little quantitative data are available
with which to evaluate protocols for the
initiation and maintenance
of
successful
lactation during the long periods
of
infant-
mother separation that commonly follow
premature delivery. De Carvalho, et al
(
19'85)1 reported that the frequency
of
milk
expression was associated positively with
milk production in mothers
of
premature
infants, but the mean volumes
of
milk pro-
duced by women in that study did not meet
the nutrient needs
of
VLBW infants and
declined production are common problems
associated with premature delivery.
A pilot study was done by the au-
thors among 10 mothers who delivered
neonates whose pediatric ages were less
than 37 weeks in a tertiary government
hospital. The total amount
of
volume
of
breastmilk expressed for 24 hours was plot-
ted from Day 1 to Day 7. Results showed
that there was a steady increase in milk
volume from days 1 to 3 after which a con-
stant
or
lower volume was recovered from
days 3 to 5. The authors determined that 3
to 5 days postpartum is critical for the suc-
cess
of
implementing a breastfeeding pro-
gram among mothers who deliver preterm
3
golacta.com. Used with permission.
infants.2
OBJECTIVES
This investigation
is
being undertaken
with the following objectives: to determine
the volume
of
breast milk that is expressed
on postpartum days 3 to 5
among
mothers
who delivered prematurely who were given
mulunggay leaves compared to those who
were given placebo
and
to determine
if
there is a significant difference
in
the vol-
ume
of
breast milk on postpartum days 3
to 5 between the two groups.
PATIENTS & METHODS
This
is
a
double-blind
randomized
controlled trial.
All mothers who delivered live infants
Jess than 37
weeks
and admitted to the
NICU
for tube feedings were eligible for
inclusion into the study. Excluded were
mothers with hypertension post-delivery,
diabetes
mellitus,
chorioamnionitis,
chronic illness
or
taking any medication
on
a regular basis, breast anomalies, and
those with infants with congenital anoma-
lies. After informed consent, mothers were
randomized using a table
of
random
num-
bers. Randomization
was
done
by a per-
son
not
involved
in the study.
Assign-
ments were concealed using sealed opaque
envelopes.
Those
assigned
to the treat-
ment group were given Moringa oleifera
leaves in a commercial capsule preparation
250
mg
every
12
hours starting
on
the
3rd
postpartum day.
Those
who were assigned
to the placebo group were given flour con-
tained in identical capsules. Capsules were
prepared by a research assistant
who
was
not directly involved in the study. Treat-
ment assignments
were
unknown
to both
the investigators and study subjects.
After proper orientation, demonstra-
tion and training, mothers were then in-
structed
to
pump
their
breasts
every
4
hours using a standardized breast pump.
Volume was measured using standardized
containers and recorded in standard note-
books provided by the study personnel.
When
available, the
volume
of
milk col-
lected
was
also
measured
by
the
study
personnel. Total
milk
volumes were tabu-
4
lated from post-partum days 3 to 5.
All data were entered using Microsoft
Excel 97. Statistical analysis
was
clone
using
SPSS
version
9.0
software.
T-test was used to determine differ-
ences
in numeric baseline variables. Chi-
square was used to determine difference
in baseline proportions between groups.
One-way
ANOVA was used to deter-
mine
if
there were significant differences
in the
collected
volume
of
breastmilk
among
mothers
on
the study medication
compared
to placebo. A p-value
of
<0.05
was
considered significant.
RESULTS
A total
of
82 mothers were recruited.
There
were
14 subjects who did
not
sub
mit
their notebooks
and
who
were consid
ered drop-outs, 9 from the treatment
grOUJ
and 5 from the control group.
There
wen
11
mothers
whose
data
were
not
complet1
because their infants expired before the
6tl
postpartum
day. Thus, a total
of
68 moth
ers
were
analyzed.
Thirty-one
(31)
moth
ers
were
in
the
Treatment
Group
and
3
~
mothers were in the Control Group.
There
is
no significant difference
ir
the gravidity,
maternal
age, and infants
pediatric ages and infants' birthweights.
The
mean
volume
of
milk collectec
among
the treatment groups from postpar·
tum
days
3 to 5 are presented in Table
~
and Figures
1.
On
day
3, the
Treatment
Group
had
2
Table
1
BASELINE CHARACTERISTICS
OF
TREATMENT
AND
CONTROL GROUP
Baseline Characteristic Treatment Group Control Group
Maternal
Age
(years) 25.8 ±
5.1
30.9 ± 15.7
Pediatric
Age
(weeks) 33.7 ±
1.9
33.1±
2.3
Infant's Weight:(grams) 1,532.7 ± 361.5 1,424.6 ± 359.2
Median gravidity 2 3
Table2
p-
value
0.09
0.30
0.22
0.32
VOLUME OF BREASTMILK (in
m1)
ON PASTPARTUM
DAYS
3 TO 5
OF TREATMENT
AND
CONTROL GROUPS
Day Post-partum Treatment Group Control Group
Day3
Day4
Day 5
114.1+1-62.9 87.2+1-49.1
190.0+-103.5
123.8
+-
84.9
319.7+-154.1
120.2+1-54.7
Figure
1
VOLUME OF BREAST MILK COLLECTED FROM
POST-PARTUM
DAYS
3 TO 5
400
300
~
g200
l3
~
~
{00
I
::r:I
~I
INTERVENTION
I
..
Plaoollo
I
o.J-.
--,..,---:---:-:----::---::,.-::-
..
___.
o
r-
OAY
p-
value
0.052
0.007
0.000
The Philippine Journal
of
Pediatrics
golacta.com. Used with permission.
mean breastmilkvolumeof 114.1 ± 62.9
m1
compared to the Control Group with a
mean
of
87.2 ± 49.1 mi. This showed a
mean difference
of20-30
ml
or
a 28-32%
increase in breast milk volume in favor
of
treatment.
On day 4, the Treatment Group had a
higher mean breast milk volume
of
190 ±
103.5 ml compared to the Control Group
with only 123.8 ± 84.9 ml. This showed a
mean difference
of
54-77 ml or a
51.:.58
%
increase in favor
of
treatment.
On day 5, the difference was even big-
ger with the Treatment Group haviiig a
breast
milk
volume of319.7 ±
154.1
m1
com-
pared to the Control Group who had 120.2
± 54
.7
mi. This had a mean difference
of
154-245
ml or a
152-176%
increase in
breast milk volume
in
favor
of
treatment.
There were no reported adverse ef-
fects in both groups. ·
DISCUSSION
Lactogenes.
is
is initiated in the post-
partum period by a fall in plasma proges-
terone in the presence
of
maintained prol-
actin
concentrations. Initiation
of
the proc-
ess does not depend on suckling
of
the
infant although the rate
of
milk secretion
after the third or fourth day postpartum
declines
if
milk removal is not practiced at
regular intervals.3 A foreign study4 on milk
volume produced by women aged 20 to 38
years who delivered at 28 to 30 weeks ges-
tation showed that optimal milk produc-
tion
was associated with five or more milk
expressions
per
day
and
pumping
durations that exceeded 100 minutes per
day.
After deli very, the basal levels
of
pro-
lactin
fall
and,
even
in
women
who
breastfeed, they
approach
the
normal
range by 2 to 3 weeks postpartum.5 When
suckling occurs prolactin is promptly re-
leased, the levels rising 5 to 10 fold for
about 30 minutes. Tactile sensitivity
of
the
nipple, markedly reduced during preg-
nancy, increases within a few hours
of
de-
livery and
is
clearly geared to efficient suck-
ling.
~
Vol.
49
No.
1 January-March 2000
In the early puerperium, the amount
of
milk
produced
correlates
with
the
amount
of
prolactin released during suck-
ling, significantly larger amounts
of
prol-
actin being released by
"good"
feeders
(over 700 ml
of
milk a day) than by "poor"
feeders, both the yield
of
milk and the
amount
of
prolactin released increases.6
Many physiologic factors influence
milk composition and volume. These in-
clude
premature
delivery,
age
of
the
mother, within-feed regulation
of
milk re-
lease, and the baby's demand for milk.'
There
is
little infonnation on milk volume
produced by mothers giving birth prema-
turely.1 Anecdotally, premature deliveries
have been associated with a decrease in
volume
of
breastmilk compared to term
deliveries because
of
the relative absence
of
sucking stimulation among mothers
of
preterm infants who cannot nurse because
of
the long infant-mother separation and
because their infants may be too small to
suckle directly.
Honnonal stimulation
of
the mammary
gland, such as occurs during nursing,
is
an
important regulator
of
amount
of
milk
produced. In the
non-nursing
mother,
breast stimulation by pump can also in-
duce prolactin release comparable with that
induced by suckling.6
As
long as sucking
stimulation continues,
in
this study, the
pumping action
of
a breast pump/reliever,
there
is
pr.oduction
of
large volumes
of
milk. Conversely,
if
there is a decrease in
blood flow, as occurs in response
to
stress,
milk secretion declines because the mam-
mary supply
of
oxygen, glucose, fatty adds,
and amino adds
is
reduced.R Maternal
stress was not evaluated during the study,
although each family was experiencing
strain due to their infants' hospitalization.
Lactagogues
or
galactogues are spe-
cial foods, drinks, or herbs which people
believe can increase a mother's milk sup-
ply.
In most parts
of
the Philippines, women
take malunggay (Moring a oleifera) leaves
mixed
in
chicken
or
shellfish soups to en-
hance breast milk production. The mecha-
nism
of
action has not been explained but
it was effective as a galactogogue and has
been used by generations
of
nursing
llJOth-
ers especially those with inadequate lac-
tation. 9
A
local
study
done
in
1996
by
Almirante and Lim demonstrated the lac-
tation-enhancing
effect
of
malunggay
leaves as evidenced by a greater increase
in
maternal serum prolactin levels and per-
centages
of
gains in the infants' weights
among the lactating mothers who took the
malunggay leaves.
10
This ca.n probably
explain its mechanism
of
actiQQ.
A follow-
up study done by the same authors among
hypertensive mothers showed similar re-
sults, with significant increases
of
tin val-
ues in the
treatment
group
(Moring a
oleifera group) compared to the placebo.
11
The authors in the same study recorded
the breastmilk volume
of
a subgroup
of
mothers (eight out
of
31
mothers) whom
they did direct measurements
of
expressed
milk on the first, second, and fourth month
postpartum. They recommenced adding
more subjects to this subgroup
of
moth-
ers to increase the level
of
significance.
11
So far, no study has demonstrated the
clinical effect
of
malunggay leaves on a
more clinically relevant outcome, that
of
breast milk volume, particularly on moth-
ers
of
pretem1 infants.
Our current study demonstrated the
lactation-enhancing effect
of
malunggay
(Natalac capsules) leaves
as
evidenced by
the significantly greater increase in the
volume
of
milk expressed by mothers on
the 3rd to the 5th postpartum day given
Moringa oleifera capsules compared to
those given placebo. The increase in vol-
ume
of
breastmilk on the third day post-
partum only had a tendency
to
be signifi-
cant at p < 0.052. This may be due to the
fact that we only started giving the treat-
ment drug (Moringa oleifera capsules) on
this day. We recommend either giving the
treatment drug earlier, probably on post-
partum day 2 or increasing the sample size
to
increase the level
of
significance for sta-
tistical analysis on day 3 postpartum.
CONCLUSION ·
We, conclude that Moringa oleifera
leaves increase the volume
of
breastmilk
produced by mothers
of
preterm infants
on post-partum days 3 to 5.
We
therefore
5
golacta.com. Used with permission.
recommend its routine use among moth-
ers of preterm infants
to
augment lacta-
tion, thereby ensuring
an
adequate sup-
ply
of
breastmilk in the population that
needs it the most.
REFERENCES
1.
De Carvalho M & Anderson
DM.
Fre-
quency of Milk Expression and Milk
Production
by
Mothers of Non-Nurs-
ing Premature Neonates. AJDC.
1985:139:483-85.
2.
Estrella MCP & Man taring
JB
III.
Vol-
ume ofBreastmilk Expressed
by
Non-
Nursing Mothers of Preterm infants
on
the First Post-partum
Week:
A Pi-
lot Study. March 1999. (Unpublished)
3.
Woolridge
MW
& Greasely
V.
The
Initiation of Lactation: The Effect
of
Early versus Delayed Contact for
7.
Suckling
on
Milk Intake in the First
Week
Postpartum. Early Human De-
velopment.
1985:
12:269-278.
Metabolism,44,
1101.
Anderson GH. Human Milk Feeding.
Pediatric Clinics of North America.
1985:
32
(2):
335-53.
4.
Hopkinson JM & Schanier
RJ.
Milk
Production
by
Mothers
of
Premature
Infants. Pediatrics. 1988:81:815-20.
5.
Neville
MC.
Regulation of Mammary
Development
and
lactation. Lactation,
Physiology,
Nutrition,
and
Breastfeeding. New York: Plenum
Press,
1983:
103-40.
6.
Aono
T,
Sihoji
T,
Shoda
T,
& Kurach
K.
The Initiation of Human Lactation
and Prolactin Response
to
Suckling.
Journal of Clinical Endocrinology
and
8.
Tucker HA. Endocrinology
of
Lacta-
tion. Seminars in Perinatology. 1979:
33:
199-223.
9.
Department
of
Health, Philippines.
Helping Mothers
to
Breastfeed. Pub-
lished
by
UNICEF,
1991.
10.
Alrnirante
CY
& Lim
CHTN.
Effective-
ness of natalac
as
a Galactogogue.
Journal
of
Philippine Medical Asso-
ciation.
1996:
71:
265-272.
11.
Almirante
CY
&
Lim
CHTN.
Enhance-
ment ofBreastfeeding Among Hyper-
tensive Mothers. Increasingly Safe
and Successful Pregnancies. 1996:
279-286.
golacta.com. Used with permission.
... More so, in the Philippines, it is known as the 'mother's best friend' because of its utilization to increase women's milk production and is sometimes prescribed for anaemia. 147,148 Equally important is the fact that few parts of the tree contain any toxins that might decrease its potential as a source of food for animals or humans. 149 ...
Article
Full-text available
Normal growth and development of the foetus during pregnancy are dependent on the general well-being of the expectant mother since she is the source of all the nutrients the foetus requires. Using a semi-structured questionnaire, data was collected from 370 self-confessed pregnant women from 28 randomly sampled suburbs of Tamale, the only city in northern Ghana to ascertain edible plants they use for preparation of meals during their period of pregnancy and the purposes for which they use these plants. Eighteen plant materials were reportedly used by these women for culinary purposes during pregnancy with the processed fermented seeds of Parkia biglobosa (Dawadawa), leaves of Amaranthus cruentus, Corchorus olitorious, Hibiscus sabdariffa, and the rhizome of Zingiber officinale being used by more than 70% of the respondents. However, Garlic (Allium sativum) and Ginger (Zingiber officinale) were the most used plant materials. The most important plant families were Malvaceae (23.0%) and Fabaceae (17.0%). Provision of good health and vitality, source of nutrients, and serving as a blood tonic were the most common reasons for the use of these plant materials for cooking and preparation of local beverages but Allium sativum was reportedly used to spiritually protect the pregnancy. Results of proximate analysis and pharmacological experiments from literature support the various purposes for which these women were using these plant materials as they are found safe for the health of mother and child and do not pose any danger to their health. There is currently no publication on culinary plants used among pregnant women from northern Ghana which in the Guinea savanna ecological zone different from that of southern Ghana. This study should increase advocacy for the increased use of these edible plant materials among pregnant women which can lead to a reduction in maternal and child mortality in Ghana
... This makes Moringa a direct stimulator of mammary gland secretory cell activity, an exciter of secretory nerve endings, an amplifier of milk secretion via prolactin, and an intensifier of transit in alveolar epithelial cells (Mutiara et al., 2013). Several other studies have reported similar results, confirming that MO primarily acts on serum prolactin levels (Estrella et al., 2000;Fungtammasan and Phupong, 2021;Raguindin et al., 2014). However, studies indicates that the presence of depression, increases the risk of general aggression, partner aggression, and self-aggression (Dutton and Karakanta, 2013). ...
Article
Mood disorders during the perinatal period, such as depression and anxiety, can have adverse consequences not only for mothers but also for their partners and offspring. In the present study, we initially investigated the developmental toxicity of aqueous extract of Morniga oleifera AEMO to ensure its safe use during prenatal period, and subsequently assessed its antidepressant and anxiolytic effects using an animal model of postpar-tum depression (PPD) induced by chronic social stress, we also evaluated its impact on maternal and the aggressive behaviors associated with PPD. The results demonstrated that AEMO exhibited at the dosage of 30 mg no abortive effect unlike 175 mg/kg/day, which indicates the safety of this dose during pregnancy and in the postpartum. AEMO ameliorated symptoms of depression and anxiety while enhanced maternal behavior in a dose dependent manner. It notably induced a significant increase in lactation and reduced maternal aggressiveness towards intruders. The use of Moringa oleifera should be monitored during the gestational period but has shown therapeutic efficacy during the postpartum period.
... The leaves of planthave been documented to be a important resource of both macro-and micro nutrients, prosperous supply of β-carotene, protein, vitamin C, calcium, and potassium and act as a superior resource of natural antioxidants; and hence improve the shelf-life of fat-containing foods (Dillard and German, 2000;Siddhuraju and Becker, 2003). Fruit (pod) sticks and leaves have been utilized to battle malnutrition, particularly amongst infants and nursing mothers for improving milk production (Dillard and German, 2000;Estrella et al., 2000) and also normalize thyroid hormone disproportion (Pal et al., 1995). The tree is significant since its flowers, pods, and leaves have therapeutic applications. ...
Chapter
Full-text available
Mushrooms are considered as good source of functional, nutritious and medicinal food. For this reason, mushroom is termed as super food. Besides this, mushroom has low calorie food with excellent sources of minerals, proteins and vitamin B complex. Mushrooms are considered as functional food for development of drugs and nutraceuticals because of rich in antioxidant, antimicrobial, antitumor properties and highly nutritional value like high protein, high fiber, low fat, low starch and low energy value. Mushroom is considered as highly perishable food, so cannot be stored for long days under ambient conditions. This factor acts as difficult in marketing for commercialization. Therefore, for preservation of mushroom, drying can be employed for extending shelf life of the mushroom. Some approaches for successful marketing can be achieved by value addition and creating process product of mushroom. Therefore, mushroom can be dried and converted into powder form for value addition of mushroom like biscuit, cookies, soup powder, papad, cake, bread, pickle, sauce, candy, noodle, etc. In this chapter, we envisaged to provide a detailed account on fortification of mushroom product.
... Moringa oleifera leaves are widely consumed and used medicinally in Asia and Africa. Nursing moms who ate these leaves showed no negative consequences, according to a tiny study [69] . Moringa may induce blood clotting, therefore it should be used with caution if anyone is prone to blood clots [70] . ...
Article
Full-text available
Nowadays, people are becoming more and more conscious of the link between nutrition, diet, and health. This bond is established from birth. In addition to being thought of as the finest nutrition for a newborn to preserve its physical and nutritional well-being, breastfeeding is usually seen as the best choice for a baby during the early stages of life. The American College of Obstetricians and Gynecologists (ACOG) advises breastfeeding exclusively for six months, after which the mother and child may decide to continue nursing in addition to introducing supplemental meals for the remainder of the baby's first year or beyond. Since breast milk includes a variety of bioactive ingredients, including proteins, vitamins, nucleotides, oligosaccharides, immunoglobulin, and some minerals, it is often regarded as the major nutritional supply for babies. A crucial opportunity for intervention to improve breastfeeding success is when inadequate supply of breast milk is often identified as the primary reason for early breastfeeding cessation. When non-drug breastfeeding support approaches fail to improve a persistently poor milk production, mothers frequently turn to drugs called galactagogues for assistance. Galactagogues function by interfering with the complex hormonal balance that controls breastfeeding, specifically with regard to prolactin and oxytocin. The available data about the effectiveness and safety of pharmacological treatments for lactation insufficiency is assessed in this narrative review. The majority of research has focused on the use of domperidone, and studies have indicated that there are modest short-term improvements for breast milk production. While there is less evidence supporting metoclopramide safety and efficacy than there is for domperidone, metoclopramide functions similarly to domperidone, thus in the event that domperidone is ineffective, it may be a good alternative for therapy. Lack of information on alternative medicines, such as metformin, oxytocin, prolactin, and herbal remedies, renders their clinical usage unreasonable. The study points out important gaps in the data and makes recommendations for possible future research topics related to galactagogues' impact on nursing.
... Moringa leaf extract can also be used as an alternative to preventing anemia in pregnant women [15]. Moringa leaves can also increase milk production on postpartum days 4-5 among mothers who give birth to premature babies [16]. One serving of Moringa leaves, namely 100 g, provides one-third of the daily requirement of calcium, and provides important amounts of iron, protein, copper, sulfur and B vitamins [17]. ...
Article
Full-text available
Pregnant women can experience stress during pregnancy. Moringa leaves as nutrition during pregnancy. By administering Moringa leaf extract, stress in pregnant women can be reduced. The purpose of this study was to determine the effect of giving Moringa capsules on stress levels in pregnant women. The results showed that the pre test was 9.53 ± 2.41, the post test score was 3.97 ± 1.45, the EPDS score decreased 5.57 ± 2.51 and based on the results of the Pairet T Test statistical test (EPDS score) was obtained (p <0.001). There is an effect of giving Moringa capsules to pregnant women on reducing stress in pregnant women in Bone District, South Sulawesi Province. From the results of this study it is hoped that the raw material for Moringa leaves can be used as the main raw material in additional food products to improve the health of pregnant, lactating women and toddlers as an effort to reduce maternal mortality, infant mortality and make it a continuation of the GAMARA'NA program.
... While neonates are in a critical developmental stage, pregnant women and nursing mothers require a consistent supply of nutrition. Because it is used to increase women's milk production, moringa is referred to as "Mother's Best Friend" [12][13][14] . It's considered a "Natural Gift of Nature." ...
Article
Full-text available
Powdered leaves of Moringa oleifera are useful in reducing stunting. Based on nutrigenomic and biological research, adding powdered Moringa oleifera leaves to supplemental foods may be beneficial to health. Molecular qualities that are anti-inflammatory, antioxidant, and anemia-preventing. Therefore, more study in these areas will be needed in the future. The moringa plant provides all of the essential elements that individuals need. They contain not only the essential nutrients but also some that aren't. Medical facilities, especially those in rural regions where malnutrition is common, should emphasize raising awareness of the nutritional and therapeutic benefits of moringa. One strategy is to brand Moringa as the "Family Tree" in order to encourage its planting in family compounds. "The purpose of this narrative review was to address undernutrition as a type of malnutrition in children, the strategies implemented in South Africa to address childhood malnutrition and its difficulties, complementary feeding practices in South Africa, particularly in KZN and the potential use of MOLP as a fortifier to increase the nutritional content of home-prepared complementary foods".
... The leaves of planthave been documented to be a important resource of both macro-and micro nutrients, prosperous supply of β-carotene, protein, vitamin C, calcium, and potassium and act as a superior resource of natural antioxidants; and hence improve the shelf-life of fat-containing foods (Dillard and German, 2000;Siddhuraju and Becker, 2003). Fruit (pod) sticks and leaves have been utilized to battle malnutrition, particularly amongst infants and nursing mothers for improving milk production (Dillard and German, 2000;Estrella et al., 2000) and also normalize thyroid hormone disproportion (Pal et al., 1995). The tree is significant since its flowers, pods, and leaves have therapeutic applications. ...
Article
Full-text available
Moringa oleifera Lam. is a pan-tropical plant well known to the ancient world for its extensive therapeutic benefits in the Ayurvedic and Unani medical systems. The ancient world was familiar with this tree, but it has only lately been rediscovered as a multifunctional species with a huge range of possible therapeutic applications. It is a folk remedy for skin diseases, edema, sore gums, etc. This review comprises the history, ethnomedicinal applications, botanical characteristics, geographic distribution, propagation, nutritional and phytochemical profile, dermatological effects, and commercially available cosmeceuticals of Moringa oleifera Lam. Compilation of all the presented data has been done by employing various search engines like Science Direct, Google, PubMed, Research Gate, EBSCO, SciVal, SCOPUS, and Google Scholar. Studies on phytochemistry claim the presence of a variety of substances, including fatty acids, phenolic acids, sterols, oxalates, tocopherols, carotenoids, flavonoids, flavonols glycosides, tannins, terpenoids, terpene, saponins, phylates, alkaloids, glucosinolates, glycosides, and isothiocyanate. The pharmacological studies have shown the efficacy of Moringa oleifera Lam. as an antibacterial, antifungal, anti-inflammatory, antioxidant, anti-atopic dermatitis, antipsoriatic, promoter of wound healing, effective in treating herpes simplex virus, photoprotective, and UV protective. As a moisturizer, conditioner, hair growth promoter, cleanser, antiwrinkle, anti-aging, anti-acne, scar removal, pigmentation, and control for skin infection, sores, as well as sweating, it has also been utilized in a range of cosmeceuticals. he Moringa oleifera Lam. due to its broad range of phytochemicals can be proven boon for the treatment of dermatological disorders.
Chapter
The mammary gland is unique, not only in its secretory products, but in its ability to complete an entire cycle of growth and differentiation each time it is called upon to provide nutrition for a new set of offspring. For this reason, in this chapter, the hormonal control of mammary development and the coordination of mammary function with other events in the female reproductive cycle are considered, along with the regulation of milk secretion and ejection. The focus will be on hormonal controls as they are understood in the human, drawing on animal studies when necessary for clarity or when information from humans is lacking. This chapter is intended to provide an overview of the complex hormonal interactions which regulate mammary function at the organismic level, making the general principles accessible to the nonspecialist. The hormonal control of mammary development will be discussed, followed by a description of prolactin secretion through the female life cycle and the role of oxytocin in milk ejection. Finally, the effects of breast-feeding on fertility and our current understanding of the interaction between nutrition and lactation will be outlined.
Article
Milk volume, day of initiation of pumping, duration and frequency of milk expression, and length of night rest interval were evaluated for the first month postpartum in 32 healthy, nonsmoking women (ages 20 to 38 years) who delivered at 28 to 30 weeks' gestation. Early milk volumes were related negatively to the delay between delivery and the initiation of milk expression (r = -.48, P less than .02). Average milk volumes at 2 weeks and 4 weeks postpartum were 493 +/- 330 and 606 +/- 369 mL/d (mean +/- SD), respectively, and were not related to the absolute frequency or duration of pumping or to night rest interval. Volume changes between weeks 2 and 4 postpartum were correlated with the absolute frequency (r = .49, P less than .01) and duration of pump use (r = .42, P less than .05) during this interval and with changes in frequency (r = 0.56, P less than .002) or duration (r = 0.49, P less than .05) between the first 2 and the second 2 weeks postpartum. Optimal milk production was associated with five or more milk expressions per day and pumping durations that exceeded 100 min/d.
Article
This article examines the factors to be considered in providing optimal nutritional care to the infant fed human milk. These factors include the nutrient and non-nutrient composition of human milk, nutrient requirements of full-term and premature infants, the timing and need for supplementary or complementary foods, and the role of milk-based formulas.
The Initiation of Human Lactation and Prolactin Response to Suckling
  • T Aono
  • T Sihoji
  • T Shoda
  • K Kurach
Aono T, Sihoji T, Shoda T, & Kurach K. The Initiation of Human Lactation and Prolactin Response to Suckling. Journal of Clinical Endocrinology and 8. Tucker HA. Endocrinology of Lactation. Seminars in Perinatology. 1979: 33: 199-223.
Effectiveness of natalac as a Galactogogue
  • C Y Alrnirante
  • Chtn Lim
Alrnirante CY & Lim CHTN. Effectiveness of natalac as a Galactogogue. Journal of Philippine Medical Association. 1996: 71: 265-272.
Enhancement ofBreastfeeding Among Hypertensive Mothers. Increasingly Safe and Successful Pregnancies
  • C Y Almirante
  • Chtn Lim
Almirante CY & Lim CHTN. Enhancement ofBreastfeeding Among Hypertensive Mothers. Increasingly Safe and Successful Pregnancies. 1996: 279-286.